Abivax SA (2X1)
FSX
Closed
Aug 24, 2026
Day's Range
101.5052 wk Range
61.35Overview - 2X1 - Abivax SA
Key Statistics
Valuation
Enterprise Value
7.44B
P/E (Trailing)
‪-20.64‬
PEG Ratio
‪0.77‬
Price / Sales (TTM)
‪1,768.13‬
Price / Book
‪18.40‬
EV / EBITDA
‪-29.32‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-4,183.70%‬
Return on Assets
‪-44.65%‬
Return on Equity
‪-157.06%‬
Ownership
Shares Outstanding
79.29M
Float
70.13M
Held by Insiders
‪4.84%‬
Held by Institutions
‪50.10%‬
Price stats
Beta
‪-0.22‬
50-Day Avg
‪107.11‬
200-Day Avg
‪103.26‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 2X1 - Abivax SA
Peers - 2X1 - Abivax SA
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 2X1FSXAbivax SA9.00BMarket Cap+36.24%52-week change-21.37P/E (Trailing)‪0.00%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.38P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+82.32%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change65.56P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - 2X1 - Abivax SA
About
Abivax SA is a clinical-stage biotechnology company that develops therapeutics designed to harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Headquartered in Paris, France, and founded in 2013, the company operates in both France and the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
